Black Hawk Acquisition Revenue Growth Rates (BKHAU), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Black Hawk Acquisition Corporation  (NASDAQ: BKHAU)
 

BKHAU's Revenue Growth by Quarter and Year

Black Hawk Acquisition's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BKHAU Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter November -
3rd Quarter August -
2nd Quarter May 0.00
1st Quarter February 0.00
FY 0.00





BKHAU Revenue second quarter 2026 Y/Y Growth Comment
Black Hawk Acquisition Corporation in the second quarter 2026 recorded of $ 0.00 millions.

According to the results reported in the second quarter 2026, Black Hawk Acquisition Corporation achieved the best Revenue growth in Biotechnology & Pharmaceuticals industry. While Black Hawk Acquisition Corporation' s Revenue no change of 0% ranks overall at the positon no. in the second quarter 2026.


BKHAU Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter November - - - -
3rd Quarter August - - - -
2nd Quarter May - - - -
1st Quarter February - - - -
FY   - - - -

Financial Statements
Black Hawk Acquisition's second quarter 2026 Revenue $ 0.00 millions BKHAU's Income Statement
Black Hawk Acquisition's second quarter 2025 Revenue $ 0.00 millions Quarterly BKHAU's Income Statement


BKHAU Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter November - - - -
3rd Quarter August - - - -
2nd Quarter May - - - -
1st Quarter February - - - -
FY (Year on Year)   - - - -


Back to BKHAU Growth rate Comparisons >> Back to BKHAU Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Black Hawk Acquisition's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BKHAU's II. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BKHAU's II. Quarter Q/Q Revenue Comment


Black Hawk Acquisition's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(May 31 2026)		 12 Months Ending
(Feb 28 2026)		 12 Months Ending
(Nov 30 2025)		 12 Months Ending
(Aug 31 2025)		 12 Months Ending
(May 31 2025)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the May 31 2026 period, Black Hawk Acquisition's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Black Hawk Acquisition Corporation achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the May 31 2026 period, Black Hawk Acquisition's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Black Hawk Acquisition Corporation achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BKHAU's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending May 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending May 31 2026
Neogen Corporation-0.58%$ -0.581 millions
Cryo cell International Inc -1.93%$ -1.926 millions
Nurix Therapeutics Inc -79.47%$ -79.474 millions


About Black Hawk Acquisition Revenue Growth Rates (BKHAU), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Black Hawk Acquisition Corp (CIK 2000775).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001829126-26-007603
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Black Hawk Acquisition Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.